Integral Health Asset Management, LLC Dyne Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

  • $850 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$23.65 - $35.63 $2.37 Million - $3.56 Million
100,000 New
100,000 $3.53 Million
Q2 2023

Aug 11, 2023
BUY
$8.53 - $14.28 $42,650 - $71,400
5,000 Added 8.77%
62,000 $697,000
Q1 2023

May 09, 2023
BUY
$10.88 - $15.0 $620,160 - $855,000
57,000 New
57,000 $656,000

Others Institutions Holding DYN

# of Institutions
209
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $697M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email